A new interpretative paradigm for conformational Protein Diseases

Current Protein and Peptide Science

Volumn 14, Issue 2, 2013, Pages 141-160

  Agnati, Luigi Francesco ^a,e   Guidolin, Diego ^b   Woods, Amina S ^c   Ciruela, Francisco ^c   Carone, Chiara ^d   Vallelunga, Annamaria ^a   Escuela, Dasiel Oscar Borroto ^e   Genedani, Susanna ^d   Fuxe, Kjell ^e  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aging; Exaptation; Neurodegenerative diseases; Prions; Protein aggregation; Protein conformation; Tinkering

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN; BETA SECRETASE 1; BETA SYNUCLEIN; COPPER ZINC SUPEROXIDE DISMUTASE; HOMOCYSTEINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR;

ALGORITHM; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CELL MEMBRANE; CONFORMATIONAL PROTEIN DISEASES; CONFORMATIONAL TRANSITION; DISEASES; FRONTOTEMPORAL DEMENTIA; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; PHOSPHORYLATION; PHYSICAL CHEMISTRY; PROTEIN CONFORMATION;

AGING; ALZHEIMER DISEASE; HUMANS; PARKINSON DISEASE; PRION DISEASES; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEINS;

EID: 84878545999     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314020006     Document Type: Article

References (219)

1. Jacob, F. La logique du vivant. Une histoire de l'hérédité. Editions Gallimard: Paris, 1970.
2. Jacob, F. Evolution and tinkering. Science,1977, 196(4295),1161-1166.
3. Gould, S.J.; Vrba, E.S. Exaptation: a missing term in the science of form. Paleobiology, 1982, 8(1), 4-15.
4. Agnati, L.F.; Guidolin, D.; Fuxe, K. The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology. J. Neural. Transm., 2007, 114(1), 3-19.
5. Agnati, L.F.; Barlow, P.; Ghidoni, R.; Borroto-Escuela, D.O.; Guidolin, D.; Fuxe, K. Possible genetic and epigenetic links between human inner speech, schizophrenia and altruism. Brain Res., 2012, In press.
6. Xu, X.; Wang, K.; Zhang, K.; Ma, Q.; Xing, L.; Sullivan, C.; Hu, D.; Cheng, S.; Wang, S. A gigantic feathered dinosaur from the lower cretaceous of China. Nature, 2012, 484(7392), 92-95.
7. Anderson, M.L. Massive redeployment, exaptation, and the functional integration of cognitive operations. Synthese, 2007, 159(3), 329-345.
8. Anderson, M.L. Neural reuse: a fundamental organizational principle of the brain. Behav. Brain Sci., 2010, 33(4), 245-313.
9. Agnati, L.F.; Fuxe, K. New concepts on the structure of the neuronal networks: the miniaturization and hierarchical organization of the central nervous system. (Hypothesis). Biosci. Rep., 1984, 4(2), 93-98.
10. Agnati, L.F.; Zoli, M.; Pich, E.M.; Benfenati, F.; Fuxe, K. Aspects of neural plasticity in the central nervous system-VII. Theoretical aspects of brain communication and computation. Neurochem. Int., 1990, 16(4), 479-500.
11. Agnati, L.F.; Guidolin, D.; Cortelli, P.; Genedani, S.; Cela-Conde, C.; Fuxe K. Neuronal correlates to consciousness. The Hall of Mirrors metaphor describing consciousness as an epiphenomenon of multiple dynamic mosaics of cortical functional modules. Brain Res., 2012, In press.
12. Agnati, L.F.; Guidolin, D.; Carone, C.; Dam, M.; Genedani, S.; Fuxe K. Understanding neuronal molecular networks builds on neuronal cellular network architecture. Brain Res. Rev., 2008, 58(2), 379-399.
13. Agnati, L.F.; Zoli, M.; Biagini, G.; Fuxe, K. Neuronal plasticity and ageing processes in the frame of the "Red Queen Theory". Acta Physiol. Scand., 1992, 145, 301-309.
14. Ray, P.D.; Huang, B.W.; Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal., 2012, 24(5), 981-990.
15. Thomas, R.J. Excitatory amino acids in health and disease. J. Am. Geriatr. Soc., 1995, 43(11), 1279-1289.
16. Algaidi, S.A.; Christie, L.A.; Jenkinson, A.M.; Whalley, L.; Riedel, G.; Platt, B. Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp Neurol., 2006, 197(1), 8-21.
17. Huber, G.; Bailly, Y.; Martin, J.R.; Mariani, J.; Brugg, B. Synaptic beta-amyloid precursor proteins increase with learning capacity in rats. Neuroscience, 1997, 80(2), 313-320.
18. Hardingham, G.E., Bading, H. The yin and yang of NMDA receptor signalling. Trends Neurosci., 2003, 26(2), 81-89.
19. Nicoll, R.A.; Malenka, R.C. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann. N.Y. Acad. Sci., 1999, 868, 515-525.
20. Lau, C.G., Zukin, R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci., 2007, 8(6), 413-426.
21. Massaad, C.A.; Klann, E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox Signal., 2011, 14(10), 2013-2054.
22. Knapp, L.T.; Klann, E. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J. Neurosci. Res., 2002, 70(1), 1-7.
23. Agnati, L.F.; Leo, G.; Genedani, S.; Piron, L.; Rivera, A.; Guidolin, D.; Fuxe, K. Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alphasynuclein. J. Neural. Transm., 2009, 116(8), 953-974.
24. Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science, 1982, 216(4542), 136-144.
25. Diaz-Espinoza, R.; Soto, C. High-resolution structure of infectious prion protein: the final frontier. Nat. Struct. Mol. Biol., 2012, 19(4), 370-377.
26. Liberski, P.P. Historical overview of prion diseases: a view from afar. Folia Neuropathol., 2012, 50(1), 1-12.
27. Agnati, L.F.; Genedani, S.; Carone, C.; Leo, G.; Fuxe, K. The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease. Curr. Proteom., 2006, 3(3),171-179.
28. Agnati, L.F.; Genedani, S.; Leo, G.; Forni, A.; Woods, A.S.; Filaferro, M.; Franco, R.; Fuxe, K. Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J. Neural. Transm., 2007, 114, 21-31.
29. Porto-Carreiro, I.; Février, B.; Paquet, S.; Vilette, D.; Raposo, G. Prions and exosomes: from PrPc trafficking to PrPsc propagation. Blood Cells Mol. Dis., 2005, 35(2), 143-148.
30. Vella, L.J.; Sharples, R.A.; Nisbet, R.M.; Cappai, R.; Hill, A.F. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur. Biophys. J., 2008, 37(3), 323-332.
31. Béringue, V.; Vilotte, J.L.; Laude, H. Prion agent diversity and species barrier. Vet. Res., 2008, 39(4), 47.
32. Afanasieva, E.G.; Kushnirov, V.V.; Ter-Avanesyan, M.D. Interspecies transmission of prions. Biochemistry (Mosc), 2011, 76(13), 1375-1384.
33. Bett, C.; Fernández-Borges, N.; Kurt, T.D.; Lucero, M.; Nilsson, K.P.; Castilla, J.; Sigurdson, C.J. Structure of the 22 loop and interspecies prion transmission. FASEB J., 2012, In press.
34. Colby, D.W.; Prusiner, S.B. De novo generation of prion strains. Nat. Rev. Microbiol., 2011, 9(11), 771-777.
35. Soto, C. Prion hypothesis: the end of the controversy? Trends Biochem. Sci., 2011, 36(3), 151-158.
36. Lupi, O.; Dadalti, P.; Cruz, E.; Sanberg, P.R.; Cryopraxis' Task Force for Prion Research. Are prions related to the emergence of early life? Med. Hypotheses., 2006, 67(5), 1027-1033.
37. Aguzzi, A.; Baumann, F.; Bremer, J. The prion's elusive reason for being. Annu. Rev. Neurosci., 2008, 31, 439-477.
38. Arendt, T. Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Progr. Neurobiol., 2003, 71(2-3), 83-248.
39. Atwood, C.S.; Obrenovich, M.E.; Liu, T.; Chan, H.; Perry, G.; Smith, M.A.; Martins, R.N. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res. Brain Res. Rev., 2003, 43(1), 1-16.
40. Agnati, L.F., Baldelli, E., Andreoli, N., Woods, A.S., Vellani, V., Marcellino, D., Guidolin, D., Fuxe, K. On the key role played by altered protein conformation in Parkinson's disease. J. Neural Transm. 2008, 115, 1285-1299.
41. Benilova, I.; Karran, E.; De Strooper, B. The toxic A oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci., 2012,15(3), 349-357.
42. Outeiro, T.F.; Giorgini, F. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Biotechnol. J., 2006, 1(3), 258-269.
43. Wickner, R.B.; Edskes, H.K.; Shewmaker, F.; Nakayashiki, T.; Engel, A.; McCann, L.; Kryndushkin, D. Yeast prions: evolution of the prion concept. Prion, 2007, 1(2), 94-100.
44. Wickner, R.B.; Edskes, H.K.; Shewmaker, F.; Nakayashiki, T. Prions of fungi: inherited structures and biological roles. Nat. Rev. Microbiol., 2007, 5(8), 611-618.
45. Winderickx, J.; Delay, C.; De Vos, A.; Klinger, H.; Pellens, K.; Vanhelmont, T.; Van Leuven, F.; Zabrocki, P. Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim. Biophys. Acta., 2008, 1783(7), 1381-1395.
46. McGurk, L.; Bonini, N.M. Cell biology. Yeast informs Alzheimer's disease. Science, 2011, 334(6060), 1212-1213.
47. Shepherd, G.M. The Synaptic Organization of the Brain. Oxford University Press: New York, 1979.
48. Golding, N.L.; Staff, N.P.; Spruston, N. Dendritic spikes as a mechanism for cooperative long-term potentiation. Nature, 2002, 418, 326-331.
49. Agnati, L.F.; Tarakanov, A.O.; Ferré, S.; Fuxe, K.; Guidolin, D. Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development. J. Mol. Neurosci., 2005, 26(2-3), 193-208.
50. Agnati, L.F.; Barlow, P.W.; Baluka, F.; Tonin, P.; Guescini, M.; Leo, G.; Fuxe, K. A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of 'predictive psychic homeostasis'. Commun. Integr. Biol., 2011, 4(6), 640-654.
51. Agnati, L.F.; Guidolin, D.; Genedani, S.; Ferré, S.; Bigiani, A.; Woods, A.S.; Fuxe K. How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. J. Mol. Neurosci., 2005, 26(2-3), 133-154.
52. Guidolin, D.; Albertin, G.; Guescini, M.; Fuxe, K.; Agnati, L.F. Central nervous system and computation. Q. Rev. Biol., 2011, 86(4), 265-285.
53. Agnati, L.F.; Guidolin, D.; Leo, G.; Guescini, M.; Pizzi, M.; Stocchi, V.; Spano, P.F.; Ghidoni, R.; Ciruela, F.; Genedani, S.; Fuxe, K. Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms. J. Recept. Signal Transduct. Res., 2011, 31(5), 315-331.
54. Agnati, L.F.; Zunarelli, E.; Genedani, S.; Fuxe, K. On the existence of a global molecular network enmeshing the whole central nervous system: physiological and pathological implications. Curr. Protein Pept. Sci., 2006, 7(1), 3-15.
55. Agnati, L.F.; Leo, G.; Zanardi, A.; Genedani, S.; Rivera, A.; Fuxe, K.; Guidolin, D. Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol. (Oxf), 2006, 187(1-2), 329-344.
56. Kuchibhotla, K.V.; Goldman, S.T.; Lattarulo, C.R.; Wu, H.Y.; Hyman, B.T.; Bacskai, B.J. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron, 2008, 59(2), 214-225.
57. Ono, K.; Condron, M.M.; Teplow, D.B. Structure-neurotoxicity relationships of amyloid -protein oligomers. Proc. Natl. Acad. Sci. USA, 2009, 106, 14745-14750.
58. Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. (Berl)., 2003, 81(11), 678-699.
59. Ramshini, H.; Parrini, C.; Relini, A.; Zampagni, M.; Mannini, B.; Pesce, A.; Saboury, A.A.; Nemat-Gorgani, M.; Chiti, F. Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils. PLoS One, 2011, 6(1), e16075.
60. Roher, A.E.; Baudry, J.; Chaney, M.O.; Kuo, Y.M.; Stine, W.B.; Emmerling, M.R. Oligomerizaiton and fibril assembly of the amyloid-beta protein. Biochim. Biophys. Acta, 2000, 1502(1), 31-43.
61. Lee, H.G.; Castellani, R.J.; Zhu, X.; Perry, G.; Smith, M.A. Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? Int. J. Exp. Pathol., 2005, 86(3), 133-138.
62. Gong, Y.; Chang, L.; Viola, K.L.; Lacor, P.N.; Lambert, M.P.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA, 2003, 100, 10417-10422.
63. Lacor, P.N.; Buniel, M.C.; Chang, L.; Fernandez, S.J.; Gong, Y.; Viola, K.L.; Lambert, M.P.; Velasco, P.T.; Bigio, E.H.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Synaptic targeting by Alzheimer'srelated amyloid beta oligomers. J. Neurosci., 2004, 24, 10191-10200.
64. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L.; Wals, P.; Zhang, C.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA, 1998, 95, 6448-6453.
65. Stéphan, A.; Laroche, S.; Davis, S. Generation of aggregated betaamyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci., 2001, 21(15), 5703-5714.
66. Dobson, C.M. Protein folding and disease: a view from the first Horizon Symposium. Nat. Rev. Drug Discov., 2003, 2(2), 154-160.
67. Lai, A.Y.; McLaurin, J. Mechanisms of amyloid-Beta Peptide uptake by neurons: the role of lipid rafts and lipid raft-associated proteins. Int. J. Alzheimers Dis., 2010, 2011, 548380.
68. Zhao, W.Q.; Santini, F.; Breese, R.; Ross, D.; Zhang, X.D.; Stone, D.J.; Ferrer, M.; Townsend, M.; Wolfe, A.L.; Seager, M.A.; Kinney, G.G.; Shughrue, P.J.; Ray, W.J. Inhibition of calcineurinmediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J. Biol. Chem., 2010, 285(10), 7619-7632.
69. DeMarco, M.L.; Daggett, V. Local environmental effects on the structure of the prion protein. http://www.ncbi.nlm.nih.gov/pubmed/16286076 C. R. Biol., 2005, 328(10-11), 847-862.
70. Aguzzi, A.; Weissmann, C. Prion research: the next frontiers. Nature, 1997, 389(6653), 795-798.
71. Goedert, M.; Clavaguera, F.; Tolnay, M. The propagation of prionlike protein inclusions in neurodegenerative diseases. Trends Neurosci., 2010, 33(7), 317-325.
72. Guest, W.C.; Silverman, J.M.; Pokrishevsky, E.; O'Neill, M.A.; Grad, L.I.; Cashman, N.R. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J. Toxicol. Environ. Health Part A, 2011, 74(22-24), 1433-1459.
73. Cushman, M.; Johnson, B.S.; King, O.D.; Gitler, A.D.; Shorter, J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell. Sci., 2010, 123(Pt 8), 1191-1201.
74. Mackenzie, I.R.; Rademakers, R.; Neumann, M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol., 2010, 9(10), 995-1007.
75. Ghidoni, R.; Benussi, L.; Binetti, G. Exosomes: the Trojan horses of neurodegeneration. Med. Hypotheses., 2008, 70(6), 1226-1227.
76. Aguzzi, A. Cell biology: Beyond the prion principle. Nature, 2009, 459(7249),924-925.
77. Agnati, L.F.; Guidolin, D.; Baluska, F.; Leo, G.; Barlow, P.W.; Carone, C.; Genedani, S. A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevance for Alzheimer's disease. Curr. Alzheimer Res., 2010, 7(4), 307-322.
78. Frost, B.; Diamond, M.I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci., 2010, 11(3), 155-159.
79. Seshadri, S.; Beiser, A.; Selhub, J.; Jacques, P.F.; Rosenberg, I.H.; D'Agostino, R.B.; Wilson, P.W.; Wolf, P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med., 2002, 346(7), 476-483.
80. Gunasekaran, K., Tsai, C.J., Kumar, S., Zanuy, D., Nussinov, R. Extended disordered proteins: targeting function with less scaffold. Trends Biochem. Sci. 2003, 28,81-85.
81. Wistow, G.J.; Lietman, T.; Williams, L.A.; Stapel, S.O.; de Jong, W.W.; Horwitz, J.; Piatigorsky, J. Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein. J. Cell. Biol., 1988, 107(6 Pt 2), 2729-2736.
82. Huberts, D.H.; van der Klei, I.J. Moonlighting proteins: an intriguing mode of multitasking. Biochim. Biophys. Acta, 2010, 1803(4), 520-525.
83. Guidolin, D., Agnati, L.F., Albertin, G., Tortorella, C., Fuxe, K. Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system. Electrophoresis 2012, 33, 3669-3679.
84. Fernandez-Escamilla, A.M.; Rousseau, F.; Schymkowitz, J.; Serrano, L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol., 2004, 22(10), 1302-1306.
85. Zibaee, S., Makin, O.S., Goedert, M., Serpell, L.C. A simple algorithm locates beta-strands in the amyloid fibril core of alphasynuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci., 2007, 16(6), 1242.
86. Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci., 2001, 2, 492-501.
87. el-Agnaf, O. M., Irvine, G. B. Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem. Soc. Trans., 2002, 30, 559-565.
88. Connell, J. W., Rodriguez-Martin, T., Gibb, G. M., Kahn, N. M., Grierson, A. J., Hanger, D. P., Revesz, T., Lantos, P. L., Anderton, B. H., Gallo, J. M. Quantitative analysis of tau isoform transcripts in sporadic tauopathies Brain Res. Mol. Brain Res. 2005, 237, 104-109.
89. Wang, Q., Johnson, J. L., Agar, N. Y., Agar, J. N. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol., 2008, 6, e170.
90. Conchillo-Solé, O.; de Groot, N.S.; Avilés, F.X.; Vendrell, J.; Daura, X.; Ventura, S. AGGRESCAN: a server for the prediction and evaluation of hot spots of aggregation in polypeptides. BMC Bioinformatics, 2007, 8, 65.
91. Bell, J.K.; Botos, I.; Hall, P.R.; Askins, J.; Shiloach, J.; Segal, D.M.; Davies, D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA, 2005, 102(31), 10976-10980.
92. Matsushima, N.; Tanaka, T.; Enkhbayar, P.; Mikami, T.; Taga, M.; Yamada, K.; Kuroki, Y. Comparative sequence analysis of leucinerich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics, 2007, 8, 124-145
93. Frousios, K.K.; Iconomidou, V.A.; Karletidi, C.M.; Hamodrakas, S.J. Amyloidogenic determinants are usually not buried. BMC Struct. Biol., 2009, 9, 44.
94. Hamodrakas, S.J. Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies. FEBS J., 2011, 278(14), 2428-2435.
95. Kim, C.; Choi, J.; Lee, S.J.; Welsh, W.J.; Yoon, S. NetCSSP: web application for predicting chameleon sequences and amyloid fibril formation. Nucleic Acids Res., 2009, 37, W469-W473.
96. Galzitskaya, O.V.; Garbuzynskiy, S.O.; Lobanov, M.Y. Prediction of amyloidogenic and disordered regions in protein chains. PLoS Comput. Biol., 2006, 2(12), e177.
97. Eisenberg, D., Jucker, M. The amyloid state of proteins in human diseases. Cell, 2012, 148, 1188-1203.
98. Malchiodi-Albedi, F.; Paradisi, S.; Matteucci, A.; Frank, C.; Diociaiuti, M. Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int. J. Alzheimers Dis., 2011, 2011, 906-964.
99. Recchia, A.; Debetto, P.; Negro, A.; Guidolin, D.; Skaper, S.D.; Giusti, P. Alpha-synuclein and Parkinson's disease. FASEB J., 2004, 18(6), 617-626.
100. Kim, C.; Lee, S.J. Controlling the mass action of alpha-synuclein in Parkinson's disease. J. Neurochem., 2008, 107(2), 303-316.
101. Forloni, G. Neurotoxicity of beta-amyloid and prion peptides. Curr. Opin. Neurol., 1996, 9(6), 492-500.
102. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Rowan, M.J.; Selkoe, D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans., 2002, 30(4), 552-557.
103. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J.I.; Van Nostrand, W.E.; Smith, S.O. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mo.l Biol., 2010, 17(5), 561-567.
104. Walsh, D.M.; Hartley, D.M.; Kusumoto, Y.; Fezoui, Y.; Condron, M.M.; Lomakin, A.; Benedek, G.B.; Selkoe, D.J.; Teplow, D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem., 1999, 274(36), 25945-25952.
105. Kane, M.D.; Lipinski, W.J.; Callahan, M.J.; Bian, F.; Durham, R.A.; Schwarz, R.D.; Roher, A.E.; Walker, L.C. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J. Neurosci., 2000, 20(10), 3606-3611.
106. Meyer-Luehmann, M.; Coomaraswamy, J.; Bolmont, T.; Kaeser, S.; Schaefer, C.; Kilger, E.; Neuenschwander, A.; Abramowski, D.; Frey, P.; Jaton, A.L.; Vigouret, J.M.; Paganetti, P.; Walsh, D.M.; Mathews, P.M.; Ghiso, J.; Staufenbiel, M.; Walker, L.C.; Jucker, M. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science, 2006, 313(5794), 1781-1784.
107. Eisele, Y.S.; Obermüller, U.; Heilbronner, G.; Baumann, F.; Kaeser, S.A.; Wolburg, H.; Walker, L.C.; Staufenbiel, M.; Heikenwalder, M.; Jucker, M. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science, 2010, 330(6006), 980-982.
108. Jucker, M.; Walker, L.C. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol., 2011, 70(4), 532-540.
109. Eisele, Y.S.; Bolmont, T.; Heikenwalder, M.; Langer, F.; Jacobson, L.H.; Yan, Z.X.; Roth, K.; Aguzzi, A.; Staufenbiel, M.; Walker, L.C.; Jucker, M. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl. Acad. Sc.i USA, 2009, 106(31), 12926-12931.
110. Hardy, J.A.; Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256(5054), 184-185.
111. Legname, G.; Baskakov, I.V.; Nguyen, H.O.; Riesner, D.; Cohen, F.E.; DeArmond, S.J.; Prusiner, S.B. Synthetic mammalian prions. Science, 2004, 305(5684), 673-676.
112. Kim, J.; Holtzman, D.M. Medicine. Prion-like behavior of amyloid-beta. Science, 2010, 330(6006), 918-919.
113. Calabrese, V.; Guagliano, E.; Sapienza, M.; Mancuso, C.; Butterfield, D.A.; Stella, A.M. Redox regulation of cellular stress response in neurodegenerative disorders. Ital. J. Biochem., 2006, 55(3-4), 263-282.
114. Dong, X.X.; Wang, Y.; Qin, Z.H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin., 2009, 30(4), 379-387.
115. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol., 2009, 7(1), 65-74.
116. Zecca, L.; Zucca, F.A.; Wilms, H.; Sulzer, D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci., 2003, 26(11), 578-580.
117. Hoozemans, J.J.; Veerhuis, R.; Van Haastert, E.S.; Rozemuller, J.M.; Baas, F.; Eikelenboom, P.; Scheper, W. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol., 2005, 110(2), 165-172.
118. Dröge, W.; Schipper, H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell., 2007, 6(3), 361-370.
119. Cookson, M.R.; van der Brug, M. Cell systems and the toxic mechanism(s) of alpha-synuclein. Exp. Neurol., 2008, 209(1), 5-11.
120. Lee, S.J. Origins and effects of extracellular a-synuclein: implications in Parkinson's disease. J. Mol. Neurosci., 2008, 34, 17-22.
121. Wang, C.; Liu, L.; Zhang, L.; Peng, Y.; Zhou, F. Redox reactions of the -synuclein-Cu(2+) complex and their effects on neuronal cell viability. Biochemistry, 2010, 49(37), 8134-8142.
122. Angot, E.; Brundin, P. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. Parkinsonism Relat. Disord., 2009, 15(Suppl 3), S143-S147.
123. Danzer, K.M.; Krebs, S.K.; Wolff, M.; Birk, G.; Hengerer, B. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J. Neurochem., 2009, 111(1), 192-203.
124. Jellinger, K.A. Interaction between -synuclein and other proteins in neurodegenerative disorders. Scientific World Journal, 2011, 11, 1893-1907.
125. Masliah, E.; Rockenstein, E.; Veinbergs, I.; Sagara, Y.; Mallory, M.; Hashimoto, M.; Mucke, L. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2001, 98(21), 12245-12250.
126. Clinton, L.K.; Blurton-Jones, M.; Myczek, K.; Trojanowski, J.Q.; LaFerla, F.M. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J. Neurosci., 2010, 30(21), 7281-7289.
127. Tsigelny, I.F.; Crews, L.; Desplats, P.; Shaked, G.M.; Sharikov, Y.; Mizuno, H.; Spencer, B.; Rockenstein, E.; Trejo, M.; Platoshyn, O.; Yuan, J.X.; Masliah, E. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One, 2008, 3(9), e3135.
128. Giasson, B.I.; Forman, M.S.; Higuchi, M.; Golbe, L.I.; Graves, C.L.; Kotzbauer, P.T.; Trojanowski, J.Q.; Lee, V.M. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science, 2003, 300(5619), 636-640.
129. Kotzbauer, P.T.; Giasson, B.I.; Kravitz, A.V.; Golbe, L.I.; Mark, M.H.; Trojanowski, J.Q.; Lee, V.M. Fibrillization of alphasynuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Exp. Neurol., 2004, 187(2), 279-288.
130. Frasier, M.; Walzer, M.; McCarthy, L.; Magnuson, D.; Lee, J.M.; Haas, C.; Kahle, P.; Wolozin, B. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp. Neurol., 2005, 192(2), 274-287.
131. Agnati, L.F.; Cortelli, P.; Pettersson, R.; Fuxe, K. The concept of trophic units in the central nervous system. Prog. Neurobiol., 1995, 46(6), 561-574.
132. Agnati, L.F.; Agnati, A.; Mora, F.; Fuxe, K. Does the human brain have unique genetically determined networks coding logical and ethical principles and aesthetics? From Plato to novel mirror networks. Brain Res. Rev., 2007, 55(1), 68-77.
133. Agnati, L.F.; Guidolin, D.; Leo, G.; Genedani, S.; Arhem, P.; Forni, A.; Andreoli, N.; Fuxe, K. Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. Curr. Protein Pept. Sci., 2007, 8(5), 460-470.
134. Cutsuridis, V.; Wennekers, T.; Graham, B.P.; Vida, I.; Taylor, J.G. Microcircuits--their structure, dynamics and role for brain function. Neural. Netw., 2009, 22(8), 1037-1038.
135. Ajmo, J.M.; Bailey, L.A.; Howell, M.D.; Cortez, L.K.; Pennypacker, K.R.; Mehta, H.N.; Morgan, D.; Gordon, M.N.; Gottschall, P.E. Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw. J. Neurochem., 2010, 113(3), 784-795.
136. Braak, H.; Del Tredici, K.; Rüb, U.; de Vos, R.A.; Jansen Steur, E.N.; Braak, E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 2003, 24(2), 197-211.
137. Braak, H.; Rüb, U.; Gai, W.P.; Del Tredici, K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural. Transm., 2003, 110(5), 517-536.
138. Lee, C.; Yu, M.H. Protein folding and diseases. J. Biochem. Mol. Biol., 2005, 38(3), 275-280.
139. Agnati, L.F.; Santarossa, L.; Benfenati, F.; Ferri, M.; Morpurgo, A.; Apolloni, B.; Fuxe, K. In: From Synapses to Rules; Apolloni, B.; Kurfes, F. Eds.; Kluwer Academic/Plenum Publishers: New York, 2002, 165-196.
140. Agnati L.F.; Franzen O.; Ferré S.; Leo G.; Franco R.; Fuxe K. Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J. Neural. Transm., 2003, 65, 195-222.
141. Agnati, L.F.; Santarossa, L.; Genedani, S.; Canela, E.I.; Leo, G.; Franco, R.; Woods, A.; Lluis, C.; Ferrè, S.; Fuxe, K. In: Computational Neuroscience: cortical dynamycs; Erdi, P.; Esposito, A.; Marinaro, M.; Scarpetta, S. Eds.; Springer: Berlin Heidelberg New York, 2004, 24-54.
142. John, N.; Krugel, H.; Frischknecht, R.; Smalla, K.H.; Schultz, C.; Kreutz, M.R.; Gundelfinger, E.D.; Seidenbecher, C.I. Brevicancontaining perineuronal nets of extracellular matrix in dissociated hippocampal primary cultures. Mol. Cell. Neurosci., 2006, 31, 774-784.
143. Frischknecht, R.; Heine, M.; Perrais, D.; Seidenbecher, C.I.; Choquet, D.; Gundelfinger, E.D. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat. Neurosci., 2009, 12, 897-904.
144. Agnati, L.F.; Fuxe, K.; Zoli, M.; Ozini, I.; Toffano, G.; Ferraguti, F. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol. Scand., 1986, 128(2), 201-207.
145. Agnati, L.F.; Guidolin, D.; Guescini, M.; Genedani, S.; Fuxe, K. Understanding wiring and volume transmission. Brain Res. Rev., 2010, 64(1), 137-159.
146. Guescini, M.; Leo, G.; Genedani, S.; Carone, C.; Pederzoli, F.; Ciruela, F.; Guidolin, D.; Stocchi, V.; Mantuano, M.; Borroto-Escuela, D.O.; Fuxe, K.; Agnati, L.F. Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures. Exp. Cell Res., 2012, 318(5), 603-613.
147. Münch, C.; O'Brien, J.; Bertolotti, A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA, 2011, 108(9), 3548-3553.
148. Emmanouilidou, E.; Melachroinou, K.; Roumeliotis, T.; Garbis, S.D.; Ntzouni, M.; Margaritis, L.H.; Stefanis, L.; Vekrellis, K. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci., 2010, 30(20), 6838-6851.
149. Rajendran, L.; Honsho, M.; Zahn, T.R.; Keller, P.; Geiger, K.D.; Verkade, P.; Simons, K. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA, 2006, 103(30), 11172-11177.
150. Vella, L.J.; Greenwood, D.L.; Cappai, R.; Scheerlinck, J.P., Hill, A.F. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet. Immunol. Immunopathol., 2008, 124(3-4), 385-393.
151. Balducci, C.; Beeg, M.; Stravalaci, M.; Bastone, A.; Sclip, A.; Biasini, E.; Tapella, L.; Colombo, L.; Manzoni, C.; Borsello, T.; Chiesa, R.; Gobbi, M.; Salmona, M.; Forloni, G. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA, 2010, 107(5), 2295-2300.
152. Gaus, K., Le Lay, S.; Balasubramanian, N.; Schwartz, M.A. Integrin-mediated adhesion regulates membrane order. J. Cell. Biol., 2006, 174(5), 725-734.
153. Patel, H.H.; Murray, F.; Insel, P.A. G-protein-coupled receptorsignaling components in membrane raft and caveolae microdomains. Handb. Exp. Pharmacol., 2008, 186, 167-184.
154. Chini, B.; Parenti, M. G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J. Mol. Endocrinol., 2009, 42(5), 371-379.
155. Patel, H.H.; Insel, P.A. Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid. Redox Signal., 2009, 11(6), 1357-1372.
156. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol., 2000, 1(1), 31-39.
157. Legate, K.R.; Wickström, S.A.; Fässler, R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev., 2009, 23(4), 397-418.
158. Clarris, H.J.; Cappai, R.; Heffernan, D.; Beyreuther, K.; Masters, C.L.; Small, D.H. Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping. J. Neurochem., 1997, 68(3), 1164-1172.
159. Mok, S.S.; Sberna, G.; Heffernan, D.; Cappai, R.; Galatis, D.; Clarris, H.J.; Sawyer, W.H.; Beyreuther, K.; Masters, C.L.; Small, D.H. Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease. FEBS Lett., 1997, 415(3), 303-307.
160. Müller, U.C.; Zheng, H. Physiological Functions of APP Family Proteins. Cold Spring Harb. Perspect. Med., 2012, 2(2), a006288.
161. Beher, D.; Hesse, L.; Masters, C.L.; Multhaup, G. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J. Biol. Chem., 1996, 271(3), 1613-1620.
162. Kibbey, M.C.; Jucker, M.; Weeks, B.S.; Neve, R.L.; Van Nostrand, W.E.; Kleinman, H.K. beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc. Natl. Acad. Sci. USA, 1993, 90(21), 10150-10153.
163. Dahms, S.O.; Hoefgen, S.; Roeser, D.; Schlott, B.; Gührs, K.H.; Than, M.E. Structure and biochemical analysis of the heparininduced E1 dimer of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA, 2010, 107(12), 5381-5386.
164. Gralle, M.; Oliveira, C.L.; Guerreiro, L.H.; McKinstry, W.J.; Galatis, D.; Masters, C.L.; Cappai, R.; Parker, M.W.; Ramos, C.H.; Torriani, I.; Ferreira, S.T. Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. J. Mol. Biol., 2006, 357(2), 493-508.
165. Wang, Z.; Wang, B.; Yang, L.; Guo, Q.; Aithmitti, N.; Songyang, Z.; Zheng, H. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J. Neurosci., 2009, 29(35), 10788-10801.
166. Cordy, J.M.; Hussain, I.; Dingwall, C.; Hooper, N.M.; Turner, A.J. Exclusively targeting -secretase to lipid rafts by GPI-anchor addition up-regulates -site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA, 2003, 100, 11735-11740.
167. Ehehalt, R.; Keller, P.; Haass, C.; Thiele, C.; Simons, K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell. Biol., 2003, 160, 113-123.
168. Vetrivel, K.S.; Thinakaran, G. Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta, 2010, 1801(8), 860-867.
169. Hebb, D.O. The Organisation of Behavior. Wiley: New York, 1949.
170. Wang, X.J. Synaptic reverberation underlying mnemonic persistent activity. Trends Neurosci., 2001, 24(8), 455-463.
171. Agnati, L.F.; Genedani, S.; Leo, G.; Rivera, A.; Guidolin, D.; Fuxe, K. One century of progress in neuroscience founded on Golgi and Cajal's outstanding experimental and theoretical contributions. Brain Res. Rev., 2007, 55, 167-189.
172. Holtmaat, A.J.; Trachtenberg, J.T.; Wilbrecht, L.; Shepherd, G.M.; Zhang, X.; Knott, G.W.; Svoboda, K. Transient and persistent dendritic spines in the neocortex in vivo. Neuron, 2005, 45(2), 279-291.
173. Welzel, O.; Tischbirek, C.H.; Jung, J.; Kohler, E.M.; Svetlitchny, A.; Henkel, A.W.; Kornhuber, J.; Groemer, T.W. Synapse clusters are preferentially formed by synapses with large recycling pool sizes. PLoS One, 2010, 5(10), e13514.
174. Fuxe, K.; Canals, M.; Torvinen, M.; Marcellino, D.; Terasmaa, A.; Genedani, S.; Leo, G.; Guidolin, D.; Diaz-Cabiale, Z.; Rivera, A.; Lundstrom, L.; Langel, U.; Narvaez, J.; Tanganelli, S.; Lluis, C.; Ferré, S.; Woods, A.; Franco, R.; Agnati, L.F. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural. Transm., 2007, 114(1), 49-75.
175. Agnati, L.F.; Guidolin, D.; Leo, G.; Carone, C.; Genedani, S.; Fuxe, K. Receptor-receptor interactions: A novel concept in brain integration. Prog. Neurobiol., 2010, 90(2), 157-175.
176. Kenakin, T.; Agnati, L.F.; Caron, M.; Fredholm, B.; Guidolin, D.; Kobilka, B.; Lefkowitz, R.W.; Lohse, M.; Woods, A.; Fuxe, K. International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached? J. Recept. Signal. Transduct. Res., 2010, 30(5), 284-286.
177. Shrestha, B.R.; Vitolo, O.V.; Joshi, P.; Lordkipanidze, T.; Shelanski, M.; Dunaevsky, A. Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol. Cell. Neurosci., 2006, 33(3), 274-282.
178. Schulz-Schaeffer, W.J. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol., 2010, 120(2), 131-143.
179. Sepulveda, F.J.; Parodi, J.; Peoples, R.W.; Opazo, C.; Aguayo, L.G. Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One, 2010, 5(7), e11820.
180. Galvin, J.E.; Lee, V.M.; Trojanowski, J.Q. Synucleinopathies: clinical and pathological implications. Arch. Neurol., 2001, 58(2), 186-190.
181. Cribbs, D.H.; Pike, C.J.; Weinstein, S.L.; Velazquez, P.; Cotman, C.W. All-D-enantiomers of -amyloid exhibit similar biological properties to all-L--amyloids. J. Biol. Chem., 1997, 272(11), 7431-7436.
182. Pitkänen, A.; Sutula, T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol., 2002, 1(3), 173-181.
183. Fowler, D.M.; Koulov, A.V.; Balch, W.E.; Kelly, J.W. Functional amyloid--from bacteria to humans. Trends Biochem. Sci., 2007, 32(5), 217-224.
184. Haass, C.; Schlossmacher, M.G.; Hung, A.Y.; Vigo-Pelfrey, C.; Mellon, A.; Ostaszewski, B.L.; Lieberburg, I.; Koo, E.H.; Schenk, D.; Teplow, D.B.; Selkoe, D.J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature, 1992, 359(6393), 322-325.
185. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature, 1992, 359, 325-327.
186. Zhang, Y.W.; Thompson, R.; Zhang, H.; Xu, H. APP processing in Alzheimer's disease. Mol. Brain, 2011, 4, 3.
187. Plant, L.D.; Boyle, J.P.; Smith, I.F.; Peers, C.; Pearson, H.A. The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J. Neurosci., 2003, 23, 5531-5535.
188. Plant, L.D.; Webster, N.J.; Boyle, J.P.; Ramsden, M.; Freir, D.B.; Peers, C.; Pearson, H.A. Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol. Aging, 2006, 27, 1673-1683.
189. Greenwald, J.; Riek, R. Biology of amyloid: structure, function, and regulation. Structure, 2010, 18(10), 1244-1260.
190. Shankar, G.M.; Walsh, D.M. Alzheimer's disease: synaptic dysfunction and Abeta. Mol. Neurodegener., 2009, 4, 48.
191. Sagan, L. On the origin of mitosing cells. J. Theor. Biol., 1967, 14(3), 225-274.
192. Camussi, G.; Deregibus, M.C.; Bruno, S.; Cantaluppi, V.; Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int., 2010, 78(9), 838-848.
193. Burke, S.N.; Barnes, C.A. Neural plasticity in the ageing brain. Nat. Rev. Neurosci., 2006, 7(1), 30-40.
194. Mahncke, H.W.; Bronstone, A.; Merzenich, M.M. Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog. Brain Res., 2006, 157,81-109.
195. Zhao, W.Q.; Santini, F.; Breese, R.; Ross, D.; Zhang, X.D.; Stone, D.J.; Ferrer, M.; Townsend, M.; Wolfe, A.L.; Seager, M.A.; Kinney, G.G.; Shughrue, P.J.; Ray, W.J. Inhibition of calcineurinmediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J. Biol. Chem., 2010, 285(10), 7619-7632.
196. Hsieh, H.; Boehm, J.; Sato, C.; Iwatsubo, T.; Tomita, T.; Sisodia, S.; Malinow, R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron, 2006, 52(5), 831-843.
197. Rui, Y.; Gu, J.; Yu, K.; Hartzell, H.C.; Zheng, J.Q. Inhibition of AMPA receptor trafficking at hippocampal synapses by betaamyloid oligomers: the mitochondrial contribution. Mol. Brain, 2010, 3, 10.
198. Kar, S.; Slowikowski, S.P.; Westaway, D.; Mount, H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci., 2004, 29(6), 427-441.
199. Khosravani, H.; Zhang, Y.; Tsutsui, S.; Hameed, S.; Altier, C.; Hamid, J.; Chen, L.; Villemaire, M.; Ali, Z.; Jirik, F.R.; Zamponi, G.W. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell. Biol., 2008, 181(3), 551-565.
200. Singh, A.; Isaac, A.O.; Luo, X.; Mohan, M.L.; Cohen, M.L.; Chen, F.; Kong, Q.; Bartz, J.; Singh, N. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog., 2009, 5(3), e1000336.
201. Torres, M.; Encina, G.; Soto, C.; Hetz, C. Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders. Commun. Integr. Biol., 2011, 4(3), 258-261.
202. Moreno, J.A.; Radford, H.; Peretti, D.; Steinert, J.R.; Verity, N.; Martin, M.G.; Halliday, M.; Morgan, J.; Dinsdale, D.; Ortori, C.A., Barrett, D.A.; Tsaytler, P.; Bertolotti, A.; Willis, A.E.; Bushell, M.; Mallucci, G.R. Sustained translational repression by eIF2 -P mediates prion neurodegeneration. Nature, 2012, 485(7399), 507-511.
203. Cabin, D.E.; Shimazu, K.; Murphy, D.; Cole, N.B.; Gottschalk, W.; McIlwain, K.L.; Orrison, B.; Chen, A.; Ellis, C.E.; Paylor, R.; Lu, B.; Nussbaum, R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci., 2002, 22(20), 8797-8807.
204. Koudinov, A.R.; Berezov, T.T. Alzheimer's amyloid-beta (A beta) is an essential synaptic protein, not neurotoxic junk. Acta Neurobiol. Exp. (Wars)., 2004, 64(1), 71-79.
205. Chandra, S.; Gallardo, G.; Fernández-Chacón, R.; Schlüter, O.M.; Südhof, T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell, 2005, 123(3), 383-396.
206. Leng, Y.; Chuang, D.M. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J. Neurosci., 2006, 26(28), 7502-7512.
207. Gitler, A.D.; Shorter, J. Prime time for alpha-synuclein. J. Neurosci., 2007, 27(10), 2433-2434.
208. Díaz-Nido, J.; Wandosell, F.; Avila, J. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides, 2002, 23(7), 1323-1332.
209. von Bernhardi, R. Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox. Res., 2007, 12(4), 215-232.
210. Yankner, B.A.; Lu, T.; Loerch, P. The aging brain. Annu. Rev. Pathol., 2008, 3, 41-66.
211. Armstrong, R.A. The pathogenesis of Alzheimer's disease: a reevaluation of the amyloid cascade hypothesis. Int. J. Alzheimers Dis., 2011, 2011, 630865.
212. Lezi, E., Swerdlow, R.H. Mitochondria in neurodegeneration Adv. Exp. Med. Biol., 2012, 942, 269-286.
213. Petruzzella, V.; Sardanelli, A.M.; Scacco, S.; Panelli, D.; Papa, F.; Trentadue, R.; Papa, S. Dysfunction of mitochondrial respiratory chain complex I in neurological disorders: genetics and pathogenetic mechanisms. Adv. Exp. Med. Biol., 2012, 942, 371-384.
214. Mancuso, C.; Scapagini, G.; Currò, D.; Giuffrida Stella, A.M.; De Marco, C.; Butterfield, D.A.; Calabrese, V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci., 2007, 12, 1107-1123.
215. Vos, M.; Lauwers, E.; Verstreken, P. Synaptic Mitochondria in Synaptic Transmission and Organization of Vesicle Pools in Health and Disease. Front. Synaptic Neurosci., 2010, 2, 139.
216. Lee, S.H.; Kim, K.R.; Ryu, S.Y.; Son, S.; Hong, H.S.; Mook-Jung, I.; Lee, S.H.; Ho, W.K. Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J. Neurosci., 2012, 32(17), 5953-5963.
217. Garden, G.A.; La Spada, A.R. Intercellular (mis)communication in neurodegenerative disease. Neuron, 2012, 73(5), 886-901.
218. Yasumatsu, N.; Matsuzaki, M.; Miyazaki, T.; Noguchi, J.; Kasai, H. Principles of Long-Term Dynamics of Dendritic Spines. J. Neurosci., 2008, 28(50), 13592-13608.
219. Lee, Y.J.; Jeong, S.Y.; Karbowski, M.; Smithl, C.L.; Youle, R.J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol. Biol. Cell, 2004, 15, 5001-5011.